The present invention relates to methods of using peptide-like compounds, e.g., aminocarboxylic acid amide derivatives, to bias the immune system toward producing, enhancing, or maintaining a polarized Th1 response, and to methods for treating diseases that improve by creating a Th1 response. The invention also relates to a method of treating diseases associated with elevated soluble TNF alpha levels by administering beta-alethine together with NAC to reduce soluble TNF alpha, and to a pharmaceutical composition comprising same. The present compounds can be used to modulate cytokines including IFN-gamma and IL-10.
本发明涉及使用肽类化合物的方法,例如
氨基
羧酸酰胺衍
生物,以偏向免疫系统产生、增强或维持极化的Th1反应,并且涉及通过创建Th1反应来治疗改善的疾病的方法。本发明还涉及一种治疗与升高的可溶性TNF alpha
水平相关的疾病的方法,该方法包括同时给予beta-alethine和
NAC以减少可溶性TNF alpha,并且涉及一种包含同样成分的药物组合物。本发明的化合物可用于调节细胞因子,包括IFN-gamma和IL-10。